Cargando…

GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling

PURPOSE: Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune system upon irradiation has been identified as a key precipitating event of OM. To better understand OM’s pathogenesis, we studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulsipher, Abigail, Savage, Justin R., Kennedy, Thomas P., Gupta, Kavita, Cuiffo, Benjamin G., Sonis, Stephen T., Lee, Won Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997003/
https://www.ncbi.nlm.nih.gov/pubmed/33770116
http://dx.doi.org/10.1371/journal.pone.0249343
_version_ 1783670228781105152
author Pulsipher, Abigail
Savage, Justin R.
Kennedy, Thomas P.
Gupta, Kavita
Cuiffo, Benjamin G.
Sonis, Stephen T.
Lee, Won Yong
author_facet Pulsipher, Abigail
Savage, Justin R.
Kennedy, Thomas P.
Gupta, Kavita
Cuiffo, Benjamin G.
Sonis, Stephen T.
Lee, Won Yong
author_sort Pulsipher, Abigail
collection PubMed
description PURPOSE: Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune system upon irradiation has been identified as a key precipitating event of OM. To better understand OM’s pathogenesis, we studied pattern recognition receptors (PRRs) and their downstream pro-inflammatory cytokines in a mouse model of radiation-induced OM. We also tested therapeutic efficacy of GM-1111 that targets innate immune system to reduce radiation-induced OM. METHODS AND MATERIALS: The pathogenesis of OM was studied in a single X-ray induced mouse model. The severity of OM was measured by visual and microscopical examinations. The irradiation-induced changes of PRRs and their downstream effector cytokine gene expression levels were determined. The efficacy of GM-1111 to reduce OM was tested in single and fractionated irradiation mouse models. The impact of the drug on tumor response to radiation therapy was also tested in a mouse model of human HNC. RESULTS: Radiation-induced tissue ulcerations were radiation-dosage and -time dependent. The lesions showed selective increases in PRR and pro-inflammatory cytokine gene expression levels. Once daily administration of GM-1111 (≥30 mg/kg, s.c.) significantly reduced the severity and the incidence of OM. The drug had little effect on PRRs but significantly inhibited downstream pro-inflammatory cytokine genes. GM-1111 did not interfere radiation therapy to induce HNC SCC-25 tumor regression. Instead, we observed significant drug-induced tumor regression. CONCLUSIONS: Radiation induces tissue damages. The increased expression levels of PRRs and their downstream pro-inflammatory cytokine genes in the damaged tissues suggest their important contribution to the pathogenesis of OM. Drug GM-1111 that targets these innate immune molecules may be a potential drug candidate as an intervention for OM.
format Online
Article
Text
id pubmed-7997003
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79970032021-04-06 GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling Pulsipher, Abigail Savage, Justin R. Kennedy, Thomas P. Gupta, Kavita Cuiffo, Benjamin G. Sonis, Stephen T. Lee, Won Yong PLoS One Research Article PURPOSE: Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune system upon irradiation has been identified as a key precipitating event of OM. To better understand OM’s pathogenesis, we studied pattern recognition receptors (PRRs) and their downstream pro-inflammatory cytokines in a mouse model of radiation-induced OM. We also tested therapeutic efficacy of GM-1111 that targets innate immune system to reduce radiation-induced OM. METHODS AND MATERIALS: The pathogenesis of OM was studied in a single X-ray induced mouse model. The severity of OM was measured by visual and microscopical examinations. The irradiation-induced changes of PRRs and their downstream effector cytokine gene expression levels were determined. The efficacy of GM-1111 to reduce OM was tested in single and fractionated irradiation mouse models. The impact of the drug on tumor response to radiation therapy was also tested in a mouse model of human HNC. RESULTS: Radiation-induced tissue ulcerations were radiation-dosage and -time dependent. The lesions showed selective increases in PRR and pro-inflammatory cytokine gene expression levels. Once daily administration of GM-1111 (≥30 mg/kg, s.c.) significantly reduced the severity and the incidence of OM. The drug had little effect on PRRs but significantly inhibited downstream pro-inflammatory cytokine genes. GM-1111 did not interfere radiation therapy to induce HNC SCC-25 tumor regression. Instead, we observed significant drug-induced tumor regression. CONCLUSIONS: Radiation induces tissue damages. The increased expression levels of PRRs and their downstream pro-inflammatory cytokine genes in the damaged tissues suggest their important contribution to the pathogenesis of OM. Drug GM-1111 that targets these innate immune molecules may be a potential drug candidate as an intervention for OM. Public Library of Science 2021-03-26 /pmc/articles/PMC7997003/ /pubmed/33770116 http://dx.doi.org/10.1371/journal.pone.0249343 Text en © 2021 Pulsipher et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pulsipher, Abigail
Savage, Justin R.
Kennedy, Thomas P.
Gupta, Kavita
Cuiffo, Benjamin G.
Sonis, Stephen T.
Lee, Won Yong
GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title_full GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title_fullStr GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title_full_unstemmed GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title_short GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
title_sort gm-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997003/
https://www.ncbi.nlm.nih.gov/pubmed/33770116
http://dx.doi.org/10.1371/journal.pone.0249343
work_keys_str_mv AT pulsipherabigail gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT savagejustinr gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT kennedythomasp gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT guptakavita gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT cuiffobenjaming gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT sonisstephent gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling
AT leewonyong gm1111reducesradiationinducedoralmucositisinmicebytargetingpatternrecognitionreceptormediatedinflammatorysignaling